Zynerba Synthetic CBD Gel Fragile X Syndrome Phase 2 Trial Succeeds



Zynerba Pharmaceuticals Announces Positive Top Line Results in ZYN002 Open Label Phase 2 FAB-C Study in Children with Fragile

... read more at: https://www.newcannabisventures.com/zynerba-synthetic-cbd-gel-fragile-x-syndrome-phase-2-trial-succeeds/

by